Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gubser

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Swiss Medical Weekly|September 30, 2011
Giant cell arteritis--a changing entityF Kesten, M Aschwanden, P Gubser, et al.
Trials|September 26, 2025
Co-Boost: boosting and guiding neuroplasticity by combining ketamine with neurofeedback-assisted learning-towards an individualised and integrated pharmaco-psychotherapy for cocaine addiction: study protocol for a randomised, placebo-controlled, double-blind, parallel-group, single-centre trialAnna S Trippel, Ladina P Gubser, Etna J E Engeli, et al.
Scientific Reports|October 14, 2023
Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differencesNathalie M Rieser, Ladina P Gubser, Flora Moujaes, et al.
Eclinicalmedicine|March 27, 2025
Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialNathalie M Rieser, Raoul Bitar, Simon Halm, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Swiss Medical Weekly|September 30, 2011
Giant cell arteritis--a changing entityF Kesten, M Aschwanden, P Gubser, et al.
Trials|September 26, 2025
Co-Boost: boosting and guiding neuroplasticity by combining ketamine with neurofeedback-assisted learning-towards an individualised and integrated pharmaco-psychotherapy for cocaine addiction: study protocol for a randomised, placebo-controlled, double-blind, parallel-group, single-centre trialAnna S Trippel, Ladina P Gubser, Etna J E Engeli, et al.
Scientific Reports|October 14, 2023
Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differencesNathalie M Rieser, Ladina P Gubser, Flora Moujaes, et al.
Eclinicalmedicine|March 27, 2025
Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialNathalie M Rieser, Raoul Bitar, Simon Halm, et al.
Pageof 1